Lance Berberian on genetic testing
From Lance Berberian - The Impact of Technology on New Healthcare Models (1/31/2019) · · NCState
“LabCorp is the leader in something called the NIPT test — the non-invasive prenatal test: you simply draw the mother's blood out of her arm, you look at the DNA circulating in the blood, you'll find a little bit that is the baby's DNA, and then you test it — that's non-invasive prenatal testing.”
On , Lance Berberian, Former Executive Vice President and Chief Information & Technology Officer at Laboratory Corporation of Amerc Holdings, spoke about genetic testing during Lance Berberian - The Impact of Technology on New Healthcare Models (1/31/2019) on NCState.
About Lance Berberian
Lance Berberian, former Executive Vice President and Chief Information & Technology Officer at Labcorp, spoke in January 2019 about the company's use of technology to transform healthcare. He described Labcorp's mission as improving health and lives through world-class diagnostics, bringing innovative medicines to patients sooner, and using technology to improve care delivery. Berberian noted that from 2014 to 2018, 46 percent of Labcorp's capital investments went into IT. He identified cybersecurity as a primary concern, stating that it was the fastest-growing part of the IT budget and that the company was applying artificial intelligence to identify zero-day attacks. Berberian discussed Labcorp's role in precision medicine, including genetic testing such as germline testing for inherited variants and oncology testing for cancer mutations. He cited the example of the BRCA variant, which he said raises breast cancer risk from 3 percent to 54 percent for women who have it. He also mentioned Labcorp's non-invasive prenatal test, which analyzes fetal DNA from a maternal blood sample. Berberian characterized the U.S. healthcare reimbursement system as "incredibly complex," noting that there are more lines of code in Labcorp's billing system than in its lab system. He added that while laboratory testing accounts for 3 percent of healthcare spending, it influences 85 percent of care decisions.